miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status

A JemalF BrayMM CenterJ FerlayE WardD FormanGlobal cancer statisticsCA Cancer J Clin616990201110.3322/caac.20107

MV IorioM FerracinCG LiuMicroRNA gene expression deregulation in human breast cancerCancer Res6570657070200510.1158/0008-5472.CAN-05-178316103053

H MouridsenA Giobbie-HurderA GoldhirschBIG 1-98 Collaborative Group: Letrozole therapy alone or in sequence with tamoxifen in women with breast cancerN Engl J Med361766776200910.1056/NEJMoa081081819692688

JF ForbesJ CuzickA BuzdarA HowellJS TobiasM BaumArimidex, Tamoxifen, Alone or in Combination GroupEffect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trialLancet Oncol94553200810.1016/S1470-2045(07)70385-618083636

Early Breast Cancer Trialist’s Collaborative GroupEffects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsLancet36516871717200515894097

GA CalinCM CroceMicroRNA signatures in human cancersNat Rev Cancer6857866200610.1038/nrc199717060945

GA CalinCM CroceMicroRNA-cancer connection: the beginning of a new taleCancer Res6673907394200610.1158/0008-5472.CAN-06-080016885332

K JeyaseelanWB HerathA ArmugamMicroRNAs as therapeutic targets in human diseasesExpert Opin Ther Targets1111191129200710.1517/14728222.11.8.111917665982

CE Stahlhut EspinosaFJ SlackThe role of microRNAs in cancerYale J Biol Med791311402006

A Esquela-KerscherFJ SlackOncomirs - microRNAs with a role in cancerNat Rev Cancer6259269200610.1038/nrc1840

SF TavazoieC AlarcónT OskarssonEndogenous human microRNAs that suppress breast cancer metastasisNature451147152200810.1038/nature0648718185580

W ZhuW QinU AtasoyER SauterCirculating microRNAs in breast cancer and healthy subjectsBMC Res Notes289200910.1186/1756-0500-2-8919454029

I FaraoniFR AntonettiJ CardoneE BonmassarmiR-155 gene: a typical multifunctional microRNABiochim Biophys Acta1792497505200910.1016/j.bbadis.2009.02.01319268705

RM O’ConnellAA ChaudhuriDS RaoD BaltimoreInositol phosphatase SHIP1 is a primary target of miR-155Proc Natl Acad Sci USA10671137118200919359473

S JiangHW ZhangMH LuMicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 geneCancer Res7031193127201010.1158/0008-5472.CAN-09-425020354188

E TiliJJ MichailleD WernickeMutator activity induced by microRNA-155 (miR-155) links inflammation and cancerProc Natl Acad Sci USA10849084913201110.1073/pnas.110179510821383199

S ValastyanF ReinhardtN BenaichA pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasisCell13710321046200910.1016/j.cell.2009.03.04719524507

S ValastyanA ChangN BenaichF ReinhardtRA WeinbergActivation of miR-31 function in already-established metastases elicits metastatic regressionGenes Dev25646659201110.1101/gad.200421121406558

S ValastyanRA WeinbergmiR-31: a crucial overseer of tumor metastasis and other emerging rolesCell Cycle921242129201010.4161/cc.9.11.1184320505365

CJ LiuSY KaoHF TuMM TsaiKW ChangSC LinIncrease of microRNA miR-31 level in plasma could be a potential marker of oral cancerOral Dis16360364201010.1111/j.1601-0825.2009.01646.x20233326

RA SiniB TrinkA NissanThe role of microRNA in tumorigenesis: key players or innocent bystandersJ Surg Oncol99135136200910.1002/jso.2121319072979

NB TsuiEK NgYM LoStability of endogenous and added RNA in blood specimens, serum, and plasmaClin Chem4816471653200212324479

PS MitchellRK ParkinEM KrohCirculating microRNAs as stable blood-based markers for cancer detectionProc Natl Acad Sci USA1051051310518200810.1073/pnas.080454910518663219

H ZhaoJ ShenL MedicoD WangCB AmbrosoneS LiuA pilot study of circulating miRNAs as potential biomarkers of early stage breast cancerPLoS One5e13735201010.1371/journal.pone.001373521060830

J ZhuXQ HuGL GuoExpression and its clinical significance of miR-155 in human primary breast cancerZhonghua Wai Ke Za Zhi482052082010(In Chinese)

N HabbeJB KoorstraJT MendellMicroRNA miR-155 is a biomarker of early pancreatic neoplasiaCancer Biol Ther8340346200910.4161/cbt.8.4.733819106647

T DonnemK EkloT BergPrognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridizationJ Transl Med96201110.1186/1479-5876-9-621219656

S VoliniaGA CalinCG LiuA microRNA expression signature of human solid tumors defines cancer gene targetsProc Natl Acad Sci USA10322572261200610.1073/pnas.051056510316461460

E TiliCM CroceJJ MichaillemiR-155: on the crosstalk between inflammation and cancerInt Rev Immunol28264284200910.1080/0883018090309379619811312

HM HeneghanN MillerAJ LoweryKJ SweeneyJ NewellMJ KerinCirculating microRNAs as novel minimally invasive biomarkers for breast cancerAnn Surg251499505201010.1097/SLA.0b013e3181cc939f20134314

CH StueltenDS SalomonmiR-31 in cancer: location mattersCell Cycle946084609201010.4161/cc.9.23.1392821260945